Summary by Moomoo AI
As of November 30, 2024, Wong Pharmaceuticals has filed its latest monthly statement of stock movements. The report showed that the company's regulated/registered share capital remained unchanged, totaling $0.15 billion with a face value of $0.1. The number of issued shares increased from 871,561,945 shares at the end of last month to 871,601,095 shares at the end of this month, an increase of 39,150 shares.The share change resulted primarily from the Share Option Plan adopted on April 24, 2015, which issued 39,150 new shares during the month. The number of shares in stock remained unchanged and there was no decrease. The Company confirms that all share issues have been authorized by the Board of Directors and are in compliance with relevant listing rules and legal requirements.Looking ahead, the company will continue to follow established share issuance plans and ensure that all procedures comply with regulatory requirements.